Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $29,036 | 20 | 71.1% |
| Consulting Fee | $7,400 | 6 | 18.1% |
| Travel and Lodging | $3,405 | 9 | 8.3% |
| Food and Beverage | $991.92 | 13 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sage Therapeutics, Inc. | $40,672 | 46 | $0 (2024) |
| TESARO, Inc. | $121.45 | 1 | $0 (2017) |
| Seagen Inc. | $39.16 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $127.97 | 1 | Sage Therapeutics, Inc. ($127.97) |
| 2023 | $39.16 | 1 | Seagen Inc. ($39.16) |
| 2022 | $8,050 | 9 | Sage Therapeutics, Inc. ($8,050) |
| 2021 | $5,510 | 6 | Sage Therapeutics, Inc. ($5,510) |
| 2020 | $23,930 | 28 | Sage Therapeutics, Inc. ($23,930) |
| 2019 | $3,054 | 2 | Sage Therapeutics, Inc. ($3,054) |
| 2017 | $121.45 | 1 | TESARO, Inc. ($121.45) |
All Payment Transactions
48 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/06/2024 | Sage Therapeutics, Inc. | ZURZUVAE (Drug) | Food and Beverage | In-kind items and services | $127.97 | General |
| Category: PSYCHIATRY/PSYCHOLOGY | ||||||
| 03/25/2023 | Seagen Inc. | — | Food and Beverage | In-kind items and services | $39.16 | General |
| 12/17/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $520.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 11/09/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,248.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 10/13/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,080.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 09/30/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Consulting Fee | Cash or cash equivalent | $2,080.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 09/30/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Food and Beverage | In-kind items and services | $40.12 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 09/27/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Food and Beverage | In-kind items and services | $99.20 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 09/22/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Travel and Lodging | Cash or cash equivalent | $354.82 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 08/30/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,248.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 01/13/2022 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Consulting Fee | Cash or cash equivalent | $380.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 11/17/2021 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $760.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 11/17/2021 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $760.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 11/10/2021 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Consulting Fee | Cash or cash equivalent | $1,140.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 07/08/2021 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $760.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 04/15/2021 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Consulting Fee | Cash or cash equivalent | $1,140.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 04/15/2021 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $950.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 12/03/2020 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $760.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 08/18/2020 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Consulting Fee | Cash or cash equivalent | $1,520.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 06/02/2020 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Consulting Fee | Cash or cash equivalent | $1,140.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 04/17/2020 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,140.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 03/13/2020 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,850.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 03/13/2020 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,140.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 03/13/2020 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,140.00 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
| 03/11/2020 | Sage Therapeutics, Inc. | ZULRESSO (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: PSYCHIATRYPSYCHOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 48 | 85 | $21,478 | $7,533 |
| 2022 | 2 | 27 | 58 | $11,771 | $4,610 |
| 2021 | 1 | 13 | 44 | $10,384 | $4,136 |
| 2020 | 1 | 13 | 50 | $11,800 | $3,983 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 26 | 63 | $15,813 | $5,370 | 34.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 11 | 11 | $4,950 | $1,886 | 38.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 11 | 11 | $715.00 | $276.87 | 38.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 46 | $10,991 | $4,299 | 39.1% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2022 | 11 | 12 | $780.00 | $310.56 | 39.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 13 | 44 | $10,384 | $4,136 | 39.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 13 | 50 | $11,800 | $3,983 | 33.8% |
About Dr. David Silver, M.D
Dr. David Silver, M.D is a Gynecologic Oncology healthcare provider based in Camp Hill, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/11/2007. The National Provider Identifier (NPI) number assigned to this provider is 1134279052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Silver, M.D has received a total of $40,833 in payments from pharmaceutical and medical device companies, with $127.97 received in 2024. These payments were reported across 48 transactions from 3 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($29,036).
As a Medicare-enrolled provider, Silver has provided services to 101 Medicare beneficiaries, totaling 237 services with total Medicare billing of $20,262. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology, Psychiatry
- Location Camp Hill, PA
- Active Since 01/11/2007
- Last Updated 12/12/2020
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1134279052
Products in Payments
- ZULRESSO (Drug) $40,544
- ZURZUVAE (Drug) $127.97
- ZEJULA (Drug) $121.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.